A defined commensal consortium elicits CD8 T cells and anti-cancer immunity.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
01 2019
Historique:
received: 26 03 2018
accepted: 05 12 2018
pubmed: 25 1 2019
medline: 20 6 2019
entrez: 25 1 2019
Statut: ppublish

Résumé

There is a growing appreciation for the importance of the gut microbiota as a therapeutic target in various diseases. However, there are only a handful of known commensal strains that can potentially be used to manipulate host physiological functions. Here we isolate a consortium of 11 bacterial strains from healthy human donor faeces that is capable of robustly inducing interferon-γ-producing CD8 T cells in the intestine. These 11 strains act together to mediate the induction without causing inflammation in a manner that is dependent on CD103

Identifiants

pubmed: 30675064
doi: 10.1038/s41586-019-0878-z
pii: 10.1038/s41586-019-0878-z
doi:

Substances chimiques

Antigens, CD 0
Histocompatibility Antigens Class I 0
Integrin alpha Chains 0
Programmed Cell Death 1 Receptor 0
alpha E integrins 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

600-605

Subventions

Organisme : NIH HHS
ID : DK43351
Pays : United States
Organisme : NIH HHS
ID : AT009708
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Auteurs

Takeshi Tanoue (T)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
JSR-Keio University Medical and Chemical Innovation Center, Tokyo, Japan.
RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Satoru Morita (S)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.

Damian R Plichta (DR)

Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Ashwin N Skelly (AN)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.

Wataru Suda (W)

RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Cooperative Major in Advanced Health Science, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.

Yuki Sugiura (Y)

Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan.

Seiko Narushima (S)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Hera Vlamakis (H)

Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Iori Motoo (I)

RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Kayoko Sugita (K)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.

Atsushi Shiota (A)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
JSR-Keio University Medical and Chemical Innovation Center, Tokyo, Japan.

Kozue Takeshita (K)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.

Keiko Yasuma-Mitobe (K)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.

Dieter Riethmacher (D)

Department of Biomedical Sciences, Nazarbayev University School of Medicine, Astana, Kazakhstan.

Tsuneyasu Kaisho (T)

Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan.

Jason M Norman (JM)

Vedanta Biosciences, Cambridge, MA, USA.

Daniel Mucida (D)

Laboratory of Mucosal Immunology, The Rockefeller University, New York, NY, USA.

Makoto Suematsu (M)

Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan.

Tomonori Yaguchi (T)

Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.

Vanni Bucci (V)

Department of Bioengineering, Program in Biotechnology and Biomedical Engineering, University of Massachusetts Dartmouth, North Dartmouth, MA, USA.

Takashi Inoue (T)

Marmoset Research Department, Central Institute for Experimental Animals, Kawasaki, Japan.

Yutaka Kawakami (Y)

Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.

Bernat Olle (B)

Vedanta Biosciences, Cambridge, MA, USA.

Bruce Roberts (B)

Vedanta Biosciences, Cambridge, MA, USA.

Masahira Hattori (M)

RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Cooperative Major in Advanced Health Science, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.

Ramnik J Xavier (RJ)

Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Center for Computational and Integrative Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Koji Atarashi (K)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
JSR-Keio University Medical and Chemical Innovation Center, Tokyo, Japan.
RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Kenya Honda (K)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan. kenya@keio.jp.
JSR-Keio University Medical and Chemical Innovation Center, Tokyo, Japan. kenya@keio.jp.
RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. kenya@keio.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH